A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab|DRUG: Paclitaxel|DRUG: Docetaxel
Sponsor: Hoffmann-La Roche